Structure-Based Design, Synthesis, Molecular Docking Study and Biological Evaluation of 1,2,4-Triazine Derivatives Acting As Cox/15-Lox Inhibitors With Anti-Oxidant Activities

Structure-Based Design, Synthesis, Molecular Docking Study and Biological Evaluation of 1,2,4-Triazine Derivatives Acting As Cox/15-Lox Inhibitors With Anti-Oxidant Activities Publisher Pubmed

Khoshneviszadeh M^{1, 2} ; Shahraki O² ; Khoshneviszadeh M^{1, 2} ; Foroumadi A³ ; Firuzi O¹ ; Edraki N¹ ; Nadri H⁴ ; Moradi A⁴ ; Shafiee A⁵ ; Miri R¹

Show Affiliations

1. Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Iran
2. Department of Medicinal Chemistry, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
3. Drug Design and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Medicinal Chemistry, Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
5. Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Enzyme Inhibition and Medicinal Chemistry Published:2016

Abstract

A set of 1,2,4-triazine derivatives were designed as cyclooxygenase-2 (COX-2) inhibitors. These compounds were synthesized and screened for inhibition of cyclooxygenases (COX-1 and COX-2) based on a cellular assay using human whole blood (HWB) and lipoxygenase (LOX-15) that are key enzymes in inflammation. The results showed that 3-(2-(benzo[d][1,3]dioxol-5-ylmethylene)hydrazinyl)-5,6-bis(4-methoxyphenyl)-1,2,4-triazine (G11) was identified as the most potent COX-2 inhibitor (78%) relative to COX-1 (50%). Ferric reducing anti-oxidant power (FRAP) assay revealed that compound G10 possesses the highest anti-oxidant activity. The compound G3 with IC50 value of 124 μM was the most potent compound in LOX inhibitory assay. Molecular docking was performed and a good agreement was observed between computational and experimental results. © 2016 Informa UK Limited, trading as Taylor & Francis Group.

Related Docs

1. Arylhydrazone Derivatives of Naproxen As New Analgesic and Anti-Inflammatory Agents: Design, Synthesis and Molecular Docking Studies, Journal of Molecular Graphics and Modelling (2016)

2. Design, Synthesis and Evaluation of Novel Multi-Target-Directed Ligands for Treatment of Alzheimer's Disease Based on Coumarin and Lipoic Acid Scaffolds, European Journal of Medicinal Chemistry (2018)

3. Synthesis and Neuroprotective Activity of Novel 1,2,4-Triazine Derivatives With Ethyl Acetate Moiety Against H2o2 and Aβ-Induced Neurotoxicity, Medicinal Chemistry Research (2017)

4. Discovery of Novel 1,2,4-Triazolo-1,2,4-Triazines With Thiomethylpyridine Hinge Binders As Potent C-Met Kinase Inhibitors, Future Medicinal Chemistry (2019)

Experts (# of related papers)

View all Related Experts

Alireza Foroumadi (2)

Mohsen Amini (1)

Style	Citing Format
MLA	Khoshneviszadeh M, et al.. "Structure-Based Design, Synthesis, Molecular Docking Study and Biological Evaluation of 1,2,4-Triazine Derivatives Acting As Cox/15-Lox Inhibitors With Anti-Oxidant Activities." Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 31, no. 6, 2016, pp. 1602-1611.
APA	Khoshneviszadeh M, Shahraki O, Khoshneviszadeh M, Foroumadi A, Firuzi O, Edraki N, Nadri H, Moradi A, Shafiee A, Miri R (2016). Structure-Based Design, Synthesis, Molecular Docking Study and Biological Evaluation of 1,2,4-Triazine Derivatives Acting As Cox/15-Lox Inhibitors With Anti-Oxidant Activities. Journal of Enzyme Inhibition and Medicinal Chemistry, 31(6), 1602-1611.
Chicago	Khoshneviszadeh M, Shahraki O, Khoshneviszadeh M, Foroumadi A, Firuzi O, Edraki N, Nadri H, Moradi A, Shafiee A, Miri R. "Structure-Based Design, Synthesis, Molecular Docking Study and Biological Evaluation of 1,2,4-Triazine Derivatives Acting As Cox/15-Lox Inhibitors With Anti-Oxidant Activities." Journal of Enzyme Inhibition and Medicinal Chemistry 31, no. 6 (2016): 1602-1611.
Harvard	Khoshneviszadeh M et al. (2016) 'Structure-Based Design, Synthesis, Molecular Docking Study and Biological Evaluation of 1,2,4-Triazine Derivatives Acting As Cox/15-Lox Inhibitors With Anti-Oxidant Activities', Journal of Enzyme Inhibition and Medicinal Chemistry, 31(6), pp. 1602-1611.
Vancouver	Khoshneviszadeh M, Shahraki O, Khoshneviszadeh M, Foroumadi A, Firuzi O, Edraki N, et al.. Structure-Based Design, Synthesis, Molecular Docking Study and Biological Evaluation of 1,2,4-Triazine Derivatives Acting As Cox/15-Lox Inhibitors With Anti-Oxidant Activities. Journal of Enzyme Inhibition and Medicinal Chemistry. 2016;31(6):1602-1611.
BibTex	@article{ author = {Khoshneviszadeh M and Shahraki O and Khoshneviszadeh M and Foroumadi A and Firuzi O and Edraki N and Nadri H and Moradi A and Shafiee A and Miri R}, title = {Structure-Based Design, Synthesis, Molecular Docking Study and Biological Evaluation of 1,2,4-Triazine Derivatives Acting As Cox/15-Lox Inhibitors With Anti-Oxidant Activities}, journal = {Journal of Enzyme Inhibition and Medicinal Chemistry}, volume = {31}, number = {6}, pages = {1602-1611}, year = {2016} }
RIS	TY - JOUR AU - Khoshneviszadeh M AU - Shahraki O AU - Khoshneviszadeh M AU - Foroumadi A AU - Firuzi O AU - Edraki N AU - Nadri H AU - Moradi A AU - Shafiee A AU - Miri R TI - Structure-Based Design, Synthesis, Molecular Docking Study and Biological Evaluation of 1,2,4-Triazine Derivatives Acting As Cox/15-Lox Inhibitors With Anti-Oxidant Activities JO - Journal of Enzyme Inhibition and Medicinal Chemistry VL - 31 IS - 6 SP - 1602 EP - 1611 PY - 2016 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract